/ Not yet recruitingEarly Phase 1IIT An Exploratory Clinical Study of the Safety and Efficacy of Anti-CD19/BCMA Chimeric Antigen Receptor NK Cell Injection in the Treatment of IgA Nephropathy
A single arm, open-label pilot study is designed to evaluate the safety and effectiveness of anti-CD19/BCMA CAR NK cells (KN5601) in patients with IgA nephropathy
100 Clinical Results associated with Jieyang People's Hospital
0 Patents (Medical) associated with Jieyang People's Hospital
100 Deals associated with Jieyang People's Hospital
100 Translational Medicine associated with Jieyang People's Hospital